Cargando…

When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening

Randomized trials on the effectiveness of screening endoscopy in reducing colorectal cancer (CRC) risk have reported statistically significant, but rather modest reduction of CRC risk by the screening offer. However, risk estimates in these trials included substantial proportions of prevalent CRC ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brenner, Hermann, Heisser, Thomas, Cardoso, Rafael, Hoffmeister, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Essay
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501935/ https://www.ncbi.nlm.nih.gov/pubmed/37530938 http://dx.doi.org/10.1007/s10654-023-01031-2

Ejemplares similares

Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
por: Chen, Xuechen, et al.
Publicado: (2023)

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey
por: Cardoso, Rafael, et al.
Publicado: (2020)

Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics
por: Heisser, Thomas, et al.
Publicado: (2021)

Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
por: Chen, Xuechen, et al.
Publicado: (2023)

Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany
por: Brenner, Hermann, et al.
Publicado: (2022)

Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
por: Heisser, Thomas, et al.
Publicado: (2020)

Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study
por: Heisser, Thomas, et al.
Publicado: (2022)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Treatment Costs of Colorectal Cancer by Sex and Age: Population-Based Study on Health Insurance Data from Germany
por: Heisser, Thomas, et al.
Publicado: (2022)

The Knowledge Graph Track at OAEI: Gold Standards, Baselines, and the Golden Hammer Bias
por: Hertling, Sven, et al.
Publicado: (2020)

Misconceptions Are “So Yesterday!”
por: Maskiewicz, April Cordero, et al.
Publicado: (2013)

A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment
por: Niedermaier, Tobias, et al.
Publicado: (2023)

The Science and Politics of Colorectal Cancer Screening
por: Hoff, Geir, et al.
Publicado: (2006)

The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
por: Gruner, Laura F., et al.
Publicado: (2021)

Sex Determination: Why So Many Ways of Doing It?
por: Bachtrog, Doris, et al.
Publicado: (2014)

A New Golden Age? Proposal for an Innovative Global Health Funding Mechanism for Middle‐Income Countries
por: Chaumont, Claire, et al.
Publicado: (2017)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
por: Schrotz-King, Petra, et al.
Publicado: (2020)

So What? A Framework for Assessing the Potential Impact of Intervention Research
por: Fielding, Jonathan E., et al.
Publicado: (2013)

Diamonds in the not-so-rough: Wild relative diversity hidden in crop genomes
por: Flint-Garcia, Sherry, et al.
Publicado: (2023)

Development of a Federally Funded Demonstration Colorectal Cancer Screening Program
por: Seeff, Laura C, et al.
Publicado: (2008)

Colorectal cancer screening: the time to act is now
por: Brenner, Hermann, et al.
Publicado: (2015)

Preventing Bias in Cluster Randomised Trials
por: Giraudeau, Bruno, et al.
Publicado: (2009)

Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis
por: Heisser, Thomas, et al.
Publicado: (2019)

When the sun rises
por: Grazionale, Karen
Publicado: (2023)

When the wrong people are immune
por: Brown, Teneille R
Publicado: (2020)

Not So Golden After All
por: Gerston, Larry
Publicado: (2012)

The Rationale for Endoscopic Spinal Surgery
por: Chung, Andrew S., et al.
Publicado: (2020)

Why Endoscopic Spine Surgery?
por: Kwon, Woo-Keun, et al.
Publicado: (2023)

Distorted Views of Biodiversity: Spatial and Temporal Bias in Species Occurrence Data
por: Boakes, Elizabeth H., et al.
Publicado: (2010)

Protecting against researcher bias in secondary data analysis: challenges and potential solutions
por: Baldwin, Jessie R., et al.
Publicado: (2022)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

History Bias, Study Design, and the Unfulfilled Promise of Pay-for-Performance Policies in Health Care
por: Naci, Huseyin, et al.
Publicado: (2016)

Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies
por: Brenner, Hermann, et al.
Publicado: (2014)

When Should Potentially False Research Findings Be Considered Acceptable?
por: Djulbegovic, Benjamin, et al.
Publicado: (2007)

Vitamin D food fortification in European countries: the underused potential to prevent cancer deaths
por: Niedermaier, Tobias, et al.
Publicado: (2022)

Causal inference—so much more than statistics
por: Pearce, Neil, et al.
Publicado: (2016)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

When Clinical Trials Are Compromised: A Perspective from a Patient Advocate
por: Mayer, Musa
Publicado: (2005)

Survival of patients with symptom- and screening-detected colorectal cancer
por: Brenner, Hermann, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_87knrdr10kmvi73654kds6cubu